Anicequol

Anicequol, a microbial secondary metabolites, is an anchorage-independent growth of tumor cells inhibitor. Anicequol inhibits the anchorage-independent growth of human colon cancer DLD-1 cells with the IC50 of 1.2 μM[1].

Product Specifications

CAS Number

[440368-05-8]

UNSPSC

12352211

Target

Endogenous Metabolite

Related Pathways

Metabolic Enzyme/Protease

Field of Research

Cancer

Smiles

C[C@@]12[C@](C[C@@H]([C@]2([H])[C@H](C)/C=C/[C@H](C)C(C)C)OC(C)=O)([H])[C@@]3([H])[C@@]([C@H](C1)O)([H])[C@@]4([C@@](C[C@H](CC4)O)([H])C([C@@H]3O)=O)C

Molecular Formula

C30H48O6

Molecular Weight

504.70

References & Citations

[1]Igarashi Y, et al. Anicequol, a novel inhibitor for anchorage-independent growth of tumor cells from Penicillium aurantiogriseum Dierckx TP-F0213. J Antibiot (Tokyo) . 2002 Apr;55 (4) :371-6.